SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert DeHaven who wrote (166)11/18/1997 6:56:00 PM
From: John McCarthy  Read Replies (1) of 1510
 
Robert -

I would like your opinion on something.

They had cash&Equi of $15.0 at Sept.

Lets say they eat $6.0+ a qtr.

Is the market price foreseeing the equity offer?

If they come out, it would be prudent to go for
at least $25.0 mil.

At $10 a pop that's 2.5 mil shares.

Have you thought about any of this?

Without news, I think we're going to be held in a tight
trading range.

If you see it different - I hope so - and please
advise.

Regards,

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News